Manipulating adenoviral vector ion-exchange chromatography: Hexon versus fiber

Jelena Ruščić, Andreja Ambriović-Ristov, Dragomira Majhen, Sandra Kolundžija, Miloš Barut, Karim Benihoud, Mladen Krajačić

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

The serotype specificity of adenovirus ion-exchange chromatography has previously been studied using standard particle-based columns, and the hexon protein has been reported to determine retention time. In this study, we have submitted Adenovirus type 5 recombinants to anion-exchange chromatography using methacrylate monolithic supports. Our experiments with hexon-modified adenoviral vectors show more precisely that the retention time is affected by the substitution of amino acids in hypervariable region 5, which lies within the hexon DE1 loop. By exploring the recombinants modified in the fiber protein, we have proven the previously predicted chromatographic potential of this surface constituent. Modifications that preserve the net charge of the hexon protein, or those that cause only a small charge difference in the fiber protein, in addition to shortening the fiber shaft, did not change the chromatographic behavior of the adenovirus particles. However, modifications that include the deletion of just two negatively charged amino acids in the hexon protein, or the introduction of a heterologous fiber protein, derived from another serotype, revealed recognizable changes in anion-exchange chromatography. This could be useful in facilitating chromatography-approach purification by creating targeted capsid modifications, thereby shifting adenovirus particles away from particular interfering substances present in the crude lysate.

Original languageEnglish
Pages (from-to)4299-4304
Number of pages6
JournalJournal of Separation Science
Volume39
Issue number22
DOIs
Publication statusPublished - 1 Nov 2016
Externally publishedYes

Keywords

  • Anion-exchange chromatography
  • Fiber protein
  • Hexon protein
  • Monolithic columns
  • Recombinant adenoviral vectors

Cite this